KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.25 $5.20 Friday, 26th Apr 2024 AVXL stock ended at $3.44. This is 1.47% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.07% from a day low at $3.38 to a day high of $3.48.
90 days $3.25 $6.82
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Mar 24, 2022 $12.55 $12.89 $12.20 $12.73 754 500
Mar 23, 2022 $12.70 $13.14 $12.40 $12.41 1 057 900
Mar 22, 2022 $12.66 $13.01 $12.56 $12.88 755 133
Mar 21, 2022 $12.89 $13.08 $12.42 $12.54 999 739
Mar 18, 2022 $12.41 $13.39 $12.41 $13.10 3 169 322
Mar 17, 2022 $11.50 $12.48 $11.47 $12.47 936 000
Mar 16, 2022 $10.82 $11.70 $10.76 $11.70 1 165 500
Mar 15, 2022 $10.12 $10.76 $10.12 $10.65 1 201 900
Mar 14, 2022 $10.97 $11.14 $9.99 $10.08 1 048 100
Mar 11, 2022 $11.26 $11.35 $10.96 $10.97 969 900
Mar 10, 2022 $10.90 $11.35 $10.77 $11.19 711 500
Mar 09, 2022 $10.70 $11.30 $10.44 $11.19 1 124 600
Mar 08, 2022 $10.16 $10.74 $9.89 $10.22 914 600
Mar 07, 2022 $10.28 $10.63 $10.12 $10.15 722 400
Mar 04, 2022 $10.53 $10.82 $10.27 $10.37 665 700
Mar 03, 2022 $10.88 $10.98 $10.42 $10.63 749 400
Mar 02, 2022 $10.67 $11.00 $10.61 $10.78 692 600
Mar 01, 2022 $10.87 $10.91 $10.33 $10.53 1 923 500
Feb 28, 2022 $10.68 $11.02 $10.38 $10.96 894 600
Feb 25, 2022 $10.67 $10.75 $10.15 $10.74 772 700
Feb 24, 2022 $9.37 $10.66 $9.28 $10.62 1 639 000
Feb 23, 2022 $10.85 $10.86 $9.73 $9.74 1 780 400
Feb 22, 2022 $11.04 $11.26 $10.70 $10.74 1 045 700
Feb 18, 2022 $11.69 $11.99 $11.31 $11.39 717 700
Feb 17, 2022 $12.50 $12.60 $11.53 $11.64 942 200
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT